IL1B and metabolic dysfunction-associated steatotic liver disease: When supplemented with FRB, liver damage was alleviated as described by significantly lower NAFLD scores and liver IL-1β levels, and slightly lower levels of liver TNF-α and plasma TBARSs (Figure 4, Table 2, Table 3 and Table 4).